CVE-2023-53734

HIGHCVSS 8.7/10EPSS 0.45%

Last modified

CVE-2023-53734 is a high-severity vulnerability rated 8.7/10 on the CVSS scale. dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.. EPSS estimates a 0.45% chance of exploitation in the next 30 days.

Description

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

Metrics

Weakness Enumeration

References

Timeline

Published
Last Modified
Status
Deferred

Frequently Asked Questions

What is CVE-2023-53734?
dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.
How severe is CVE-2023-53734?
CVE-2023-53734 has a CVSS score of 8.7/10 (HIGH severity). The EPSS model estimates a 0.45% probability of exploitation in the next 30 days.
How do I fix CVE-2023-53734?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2023

Are you affected by CVE-2023-53734?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST